Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Excessive Sleepiness

In brief

This is a randomized, double-blind, placebo-controlled, parallel-group study of armodafinil and placebo treatment in healthy subjects with excessive sleepiness associated with jet lag disorder.

Key facts

Study ID

NCT00758498

Run by

Cephalon

People needed

427

Starts

2008-09-01

Expected to finish

2009-02-01

Last updated by the study team

2013-07-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Where it is running

• Neurotrials Research, Inc. — Atlanta, Georgia, United States
• Community Research — Crestview, Kentucky, United States
• Clinilabs, Inc. — New York, New York, United States
• SleepMed of South Carolina — Columbia, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.